POWDERMED
PowderMed developed vaccines for the treatment of chronic infectious diseases and cancer. The company used DNA coated gold particles delivered by a needle-free injection device to stimulate a powerful and specific T cell immune response.
POWDERMED
Industry:
Health Care Medical Therapeutics
Founded:
2004-01-01
Address:
Oxford, Oxfordshire, United Kingdom
Country:
United Kingdom
Total Employee:
1+
Status:
Active
Contact:
+441865501500
Total Funding:
20 M GBP
Similar Organizations
CorneaCare
Personalized dry eye treatment delivered and monitored.
Nobias Therapeutics
Nobias Therapeutics is a developer of rare pediatric disease drugs intended to cure rare illnesses in children.
Current Employees Featured
Founder
Investors List
Abingworth
Abingworth investment in Series A - PowderMed
Advent Venture Partners
Advent Venture Partners investment in Series A - PowderMed
Oxford Bioscience Partners
Oxford Bioscience Partners investment in Series A - PowderMed
SV Health Investors
SV Health Investors investment in Series A - PowderMed
Schroder Ventures
Schroder Ventures investment in Series A - PowderMed
More informations about "PowderMed"
PowderMed - VentureRadar
PowderMed developed the Particle Mediated Epidermal Delivery (PMED) technology. PMED delivers DNA vaccines into the skin without needles in a dry powder formulation of gold …See details»
PowderMed Company Profile 2024: Valuation, Investors
PowderMed was founded in 2004. Where is PowderMed headquartered? PowderMed is headquartered in Oxford, United Kingdom. What is the size of PowderMed? PowderMed has …See details»
PowderMed - Products, Competitors, Financials, Employees, …
PowderMed develops vaccine for the treatment of chronic infectious diseases and cancer. The company uses deoxyribonucleic acid (DNA) coated gold particles delivered by a needle-free …See details»
PowderMed - Company Profile - Tracxn
3 days ago The particles are accelerated by helium gas in a hand-held device and propelled into the skin. This needle-free delivery is ideal for the delivery of DNA vaccines. PowderMed was …See details»
Pfizer Breaks into the DNA-based Vaccine Market
Oct 10, 2006 Acquisition of PowderMed adds to company’s pipeline. Pfizer acquired PowderMed, a privately held U.K. company specializing in DNA-based vaccines with a …See details»
PowderMed - Funding, Financials, Valuation & Investors
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . May 24, 2004: Series A - …See details»
Pfizer Inc. Expands Commitment To Fight Infectious Diseases
Oct 9, 2006 Rolf Stahel Chairman of PowderMed Ltd. added, “PowderMed is a great success story. Through the financial support of a syndicate of leading life science investors and an …See details»
Pfizer agreement to acquire Powdermed Ltd. - Acquisition Marks ...
Oct 10, 2006 PowderMed has DNA-based influenza vaccines in clinical development for prevention of both seasonal and avian flu. The most advanced candidate is entering Phase II …See details»
PowderMed - Crunchbase
PowderMed developed the Particle Mediated Epidermal Delivery (PMED) technology.See details»
PowderMed | Advent Life Sciences
PowderMed developed the Particle Mediated Epidermal Delivery (PMED) technology for needle-free delivery of DNA vaccines into the skin as a dry powder formulation of gold particles. CEO Clive Dix Advent Contact Raj ParekhSee details»
Pfizer buys British vaccine company PowderMed - Pharmafile
Oct 12, 2006 Pfizer will gain entry into the fast-growing vaccines market by buying PowderMed, the British company developing next generation products in the field.PowderMed's vaccine …See details»
Pfizer to acquire vaccine maker PowderMed - The Pharma Letter
Oct 15, 2006 "There is a critical public health need for new, more effective vaccines to prevent and treat infectious diseases. As understanding of the human immune system continues to …See details»
PowderMed Launched in Spin Out of Powder Injection DNA …
Oxford, UK - PowderMed Ltd (PowderMed), a new company focussing on the development of therapeutic DNA vaccines, was officially launched today.The Company has been created …See details»
New UK-based vaccines firm, PowderMed, spins out from Chiron
May 23, 2004 New UK-based vaccines firm, PowderMed, spins out from Chiron 23 May 2004 PowderMed Ltd, a new UK-based company focused on the development of therapeutic DNA …See details»
PowderMed's Vaccines: Out of Chiron, Into the Clinic - In Vivo
Jan 1, 2003 The spinout of PowderJect's DNA vaccine technology following that company's acquisition by Chiron in mid-2003 was no surprise-these powder-injection assets are far too …See details»
PowderMed - Tech Stack, Apps, Patents & Trademarks - Crunchbase
Organization. PowderMed . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Patents and Trademarks by IPqwery. Edit Patents and …See details»
PowderMed - Contacts, Employees, Board Members, Advisors
Organization. PowderMed . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 2. About. PowderMed has …See details»
Powdermed - selectscience.net
Find Powdermed products, product reviews and resources on SelectScience (Opens in new tab) (Opens in new tab) (Opens in new tab) Login Join Free. Fields & Topics. Life Sciences. All …See details»
John Beadle - Crunchbase Person Profile
John Beadle is the Co-Founder at PowderMed. ... Organization Name . Title At Company . Start Date . End Date . Akamis Bio . Founder and Chief Executive Officer: Dec 2009: 2021: …See details»